IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258,727 | -86.0% | 36,751 | -87.9% | 0.00% | -88.9% |
| Q1 2023 | $1,848,384 | -71.0% | 302,518 | -69.7% | 0.02% | -66.0% |
| Q4 2022 | $6,377,859 | +284.7% | 998,100 | +476.3% | 0.05% | +278.6% |
| Q3 2022 | $1,658,000 | -26.6% | 173,183 | +89.0% | 0.01% | -39.1% |
| Q3 2021 | $2,260,000 | +845.6% | 91,641 | +896.1% | 0.02% | +666.7% |
| Q2 2021 | $239,000 | -74.4% | 9,200 | -68.8% | 0.00% | -72.7% |
| Q1 2021 | $935,000 | +141.6% | 29,501 | +254.1% | 0.01% | +120.0% |
| Q4 2020 | $387,000 | -76.9% | 8,332 | -83.7% | 0.01% | -84.4% |
| Q3 2020 | $1,678,000 | -29.5% | 50,969 | -41.2% | 0.03% | 0.0% |
| Q2 2020 | $2,380,000 | +555.6% | 86,718 | +614.6% | 0.03% | +39.1% |
| Q1 2020 | $363,000 | -94.2% | 12,135 | -94.7% | 0.02% | -85.0% |
| Q4 2019 | $6,278,000 | +141.8% | 226,851 | +59.1% | 0.15% | +101.3% |
| Q3 2019 | $2,596,000 | +435.3% | 142,600 | +620.2% | 0.08% | +347.1% |
| Q2 2019 | $485,000 | -73.0% | 19,800 | -89.5% | 0.02% | -72.6% |
| Q1 2019 | $1,793,000 | -78.4% | 188,430 | -79.9% | 0.06% | -80.6% |
| Q4 2018 | $8,304,000 | +1564.1% | 938,300 | +3076.3% | 0.32% | +762.2% |
| Q1 2018 | $499,000 | +99.6% | 29,541 | -13.2% | 0.04% | +42.3% |
| Q2 2017 | $250,000 | – | 34,024 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |